Risk factors for antimicrobial use in veal calves and the association with mortality.

The intensive use of antimicrobials in the veal industry is heavily criticized, but drivers for antimicrobial usage (AMU) are still poorly understood. The industry fears that a drastic reduction in AMU would increase mortality, creating an unacceptable welfare issue. The objectives of the present study were to identify risk factors for AMU and to explore the relationship between AMU and mortality. A retrospective cohort study was performed on the antimicrobial registration data from the largest Belgian veterinary veal practice. The data set contained 295 production cycles from 78 farms, representing 146,014 calves and 8 veal companies (also called integrations). The average AMU was 32.3 defined daily dose animal per year (standard deviation: 11.04), of which 76.2% was administered orally and 23.8% parentally. The AMU remained stable between 2014 and 2016 with only a slight, but significant increase in total AMU between 2015 (31.0 defined daily dose animal per year, standard deviation: 10.5) and 2016 (35.1, 10.8). Use of almost all antimicrobial classes decreased over 2014 to 2016; however, use of long-acting macrolides, doxycycline, and aminosides increased significantly. Analysis identified breed (higher use in beef calves compared with dairy and crossbreeds), month of arrival (lower use when arrived in April or May compared with winter months), and veal company as risk factors. The veal company not only significantly affected total AMU, but also affected the majority of the antimicrobial classes. Additionally, breed differences were present for oxytetracycline, colistin, and classic macrolides, and a month effect was present for doxycycline only. These data illustrate that this veterinary practice realized a reduction of 46% in total AMU and of 96% in critically important antibiotics (fluoroquinolones, cephalosporins of the third and fourth generation) compared with the Belgian benchmark from 2007 to 2009. Replacement of critically important drugs by an increased use of long-acting macrolides is worrisome. Mortality risk was very low compared with benchmarks referenced internationally and did not increase with decreasing AMU. Use of trimethoprim-sulfonamides was a risk factor, whereas use of oxytetracycline was a protective factor for mortality. The absence of a relationship with mortality at the current levels of AMU suggests that a further rational reduction is possible. Attention should be paid to consider different AMU benchmarks for different breeds and to include the veal company as a target for antibiotic awareness campaigns.

[1]  J. Dewulf,et al.  Risk factors for antimicrobial use in food-producing animals: disease prevention and socio-economic factors as the main drivers? , 2018, Vlaams Diergeneeskundig Tijdschrift.

[2]  D. Kelton,et al.  Risk factors associated with mortality at a milk-fed veal calf facility: A prospective cohort study. , 2017, Journal of dairy science.

[3]  J. Dewulf,et al.  Associations between a decreased veterinary antimicrobial use and resistance in commensal Escherichia coli from Belgian livestock species (2011-2015). , 2017, Preventive veterinary medicine.

[4]  E. Morignat,et al.  Quantitative and qualitative analysis of antimicrobial usage in white veal calves in France. , 2017, Preventive veterinary medicine.

[5]  C. Carson,et al.  Antimicrobial use surveillance in broiler chicken flocks in Canada, 2013-2015 , 2017, PloS one.

[6]  N. Toft,et al.  A register-based study of the antimicrobial usage in Danish veal calves and young bulls , 2016, Preventive Veterinary Medicine.

[7]  G. Schüpbach-Regula,et al.  Antimicrobial drug use and risk factors associated with treatment incidence and mortality in Swiss veal calves reared under improved welfare conditions. , 2016, Preventive veterinary medicine.

[8]  G. Schüpbach-Regula,et al.  Effect of calf purchase and other herd-level risk factors on mortality, unwanted early slaughter, and use of antimicrobial group treatments in Swiss veal calf operations. , 2016, Preventive veterinary medicine.

[9]  C. Greko,et al.  Antibiotic resistance—consequences for animal health, welfare, and food production , 2014, Upsala journal of medical sciences.

[10]  J. Dewulf,et al.  Correlation between veterinary antimicrobial use and antimicrobial resistance in food-producing animals: a report on seven countries. , 2014, The Journal of antimicrobial chemotherapy.

[11]  J. Dewulf,et al.  Characteristics and challenges of the modern Belgian veal industry , 2014 .

[12]  M. Hostens,et al.  Prospective study on quantitative and qualitative antimicrobial and anti-inflammatory drug use in white veal calves. , 2012, The Journal of antimicrobial chemotherapy.

[13]  M. Hostens,et al.  Longitudinal study on morbidity and mortality in white veal calves in Belgium , 2012, BMC Veterinary Research.

[14]  A. Steiner,et al.  Risk factors for death and unwanted early slaughter in Swiss veal calves kept at a specific animal welfare standard. , 2012, Research in veterinary science.

[15]  Lan Ge,et al.  A Bayesian Belief Network to Infer Incentive Mechanisms to Reduce Antibiotic Use in Livestock Production , 2014 .

[16]  J. Dewulf,et al.  Prevalence of respiratory pathogens in diseased, non-vaccinated, routinely medicated veal calves , 2011, Veterinary Record.

[17]  A. de Kruif,et al.  Quantification and evaluation of antimicrobial drug use in group treatments for fattening pigs in Belgium. , 2006, Preventive veterinary medicine.

[18]  P. Lekeux,et al.  Spirometric variables recorded after lobeline administration in healthy Friesian and Belgian white and blue calves: normal values and effects of somatic growth. , 1999, The Veterinary Journal.

[19]  A. Andrews Factors affecting the incidence of pneumonia in growing bulls , 1976, Veterinary Record.